Immunoglobulin Heavy Chain Gene Rearrangement in Non B-cell Haematological Malignancies

Area of Science:

• Hematology
• Oncology
• Molecular Diagnostics

Background:

• Clonality detection using immunoglobulin heavy chain (IGH) gene rearrangements via polymerase chain reaction (PCR) is crucial for diagnosing B-lymphoid malignancies.
• IGH gene rearrangement serves as an optimal target for assessing clonality in B-lymphoid cancers.

Purpose of the Study:

• To evaluate the presence of IGH gene rearrangement in non B-cell hematologic malignancies.
• To investigate IGH gene rearrangement in T-cell acute lymphoblastic leukemia (T-ALL), acute myeloid leukemia (AML), and biphenotypic leukemia.

Main Methods:

• Studied 18 cases of hematological malignancies.
• Included five patients with T-ALL, 12 with AML, and one with biphenotypic leukemia.
• Utilized PCR to amplify IGH gene rearrangements.

Main Results:

• IGH gene rearrangement was detected in 60% of T-ALL cases (3 out of 5).
• IGH gene rearrangement was found in 16.7% of AML cases (2 out of 12).
• The single biphenotypic leukemia case tested negative for IGH gene rearrangement.

Conclusions:

• While IGH gene rearrangement is characteristic of B-cell malignancies, it can occur in a small subset of T-cell and myeloid malignancies.
• This finding highlights the potential for IGH gene rearrangement as a diagnostic marker beyond B-cell lineage.